Product details
| Commercial name | Canigen L |
| Authorization number | 220052 |
| Authorization status | Valida |
| Authorization date | 15-03-2022 |
| Authorization valid date | nelimitata |
| Active substance | L. interrogans, serogrup canicola, L. interrogans, serogrup icterohaemorrhagiae |
| Target species | câini |
| Therapeutical action | Caini Imunoprofilaxia leptospirozei. |
| Therapeutic group | Produse biologice |
| Pharmaceutical form | liofilizat şi solvent pentru suspensie injectabilă |
| Packaging | flacon x 1 ml |
| Withdrawal period | Nu este cazul. |
| Manufacturer | VIRBAC S.A., Franţa |
| Licence owner | VIRBAC S.A., Franţa |
| Romanian responsible company | ALTIUS SA |
| Link to prospectus | click aici pentru a vizualiza prospectul |
| Link to authorization | |
| Notes | Autorizat prin DCP. |
| Release Mode | Cu prescripţie |
| Authorization variations | |||
|
I. Variatii care necesita evaluare (VRA): |
|||
| Variation No. | Date | Variation type | Description |
| 1 | 17-06-2024 | G.I.18 | Alinierea informatiilor despre produs cu versiunea QRD 9.0, adica actualizarea majora a formatelor QRD, conform Regulamentului (UE) 2019/6, pentru produse medicinale veterinare introduse pe piata in conformitate cu Directiva 2001/82/CE, Directiva 2001/82/CE sau Regulamentul (CE) nr. 726 / 2004. |
| Authorizations history | ||||
| Commercial name | Authorization number | Authorization date | Authorization valid date | Authorization status |
| Canigen L | 170204 | 21-09-2017 | 21-09-2022 | Anulata |

